Catalyst Wire Dossier Catalyst Wire Dossier

Cinainu

· Legacy Healthcare (France) S.A.S.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cinainu, covering 2025-05-26 to 2025-05-26. Get the full timeline:

Most recent: EMA Application withdrawn: Cinainu (dry aqueous extract of paullinia cupana seed;dry hydroethanolic extract of theobroma cacao seed;liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh fruit) — Legacy Healthcare (France) S.A.S.

See pricing